CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 54 filers reported holding CIDARA THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $7,000 | -86.3% | 11,672 | -15.7% | 0.00% | – |
Q2 2020 | $51,000 | +13.3% | 13,838 | +17.8% | 0.00% | – |
Q4 2019 | $45,000 | +73.1% | 11,750 | -9.6% | 0.00% | – |
Q3 2019 | $26,000 | -93.9% | 13,000 | -94.9% | 0.00% | -100.0% |
Q2 2019 | $428,000 | -46.1% | 255,000 | -14.9% | 0.00% | 0.0% |
Q1 2019 | $794,000 | +1.9% | 299,667 | -9.6% | 0.00% | 0.0% |
Q4 2018 | $779,000 | -26.2% | 331,351 | +38.2% | 0.00% | -50.0% |
Q3 2018 | $1,055,000 | +3.5% | 239,798 | +22.4% | 0.00% | 0.0% |
Q2 2018 | $1,019,000 | +165.4% | 195,878 | +104.1% | 0.00% | +100.0% |
Q1 2018 | $384,000 | +125.9% | 95,951 | +284.1% | 0.00% | – |
Q4 2017 | $170,000 | -32.8% | 24,983 | -19.9% | 0.00% | -100.0% |
Q3 2017 | $253,000 | +35.3% | 31,206 | +25.2% | 0.00% | – |
Q2 2017 | $187,000 | – | 24,928 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 1,172,044 | $2,625,000 | 2.31% |
Stonepine Capital Management, LLC | 782,817 | $1,754,000 | 0.80% |
5AM Venture Management, LLC | 1,134,511 | $2,541,000 | 0.52% |
Omega Fund Management, LLC | 2,005,249 | $4,492,000 | 0.50% |
BVF INC/IL | 4,776,904 | $10,700,000 | 0.42% |
KNOTT DAVID M | 415,308 | $930,000 | 0.34% |
West Family Investments, Inc. | 368,910 | $826,000 | 0.21% |
Monashee Investment Management LLC | 369,099 | $827,000 | 0.15% |
JEPPSON WEALTH MANAGEMENT, LLC | 60,100 | $134,000 | 0.07% |
Pacifica Partners Inc. | 8,000 | $18,000 | 0.01% |